Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04755764 · ClinicalTrials.gov registry record
Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
A clinical trial of Pregnancy Related and Cardiac Output, Low, sponsored by Marshall University.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT04755764: Recruiting study of Pregnancy Related and Cardiac Output, Low, sponsored by Marshall University.
NCT04755764 is a study of Pregnancy Related and Cardiac Output, Low that is actively recruiting participants, run by Marshall University. The registered enrollment target is 60 participants, below the 1,962-participant average among 99 other Pregnancy Related trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04755764, a study of Pregnancy Related and Cardiac Output, Low, is actively recruiting participants, sponsored by Marshall University.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynamics and asked to return for a repeat measurement.
Primary Outcome
Measured in mmHg
Conditions Studied
Interventions
- DRUG Labetalol
- DRUG Atenolol
- DRUG Nifedipine
Study Locations (1)
West Virginia
- Maternal Hypertension Center at Cabell Huntington Hospital - Huntington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-03-03 |
| Est. Completion | 2025-12 |
What NCT04755764 shows while recruiting
NCT04755764 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,962-participant average among 99 other Pregnancy Related trials with a reported enrollment target (97% lower).
The record links to 5 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 3 interventions - of which Labetalol is the first listed.
NCT04755764 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT04755764 about?
NCT04755764 is a clinical study titled "Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy". The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynamics and asked to return for a repeat measurement.
What is the current status of trial NCT04755764?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2021-03-03. Estimated completion is 2025-12.
What conditions does trial NCT04755764 study?
This clinical trial studies the following conditions: Pregnancy Related, Cardiac Output, Low, Systolic Hypertension, Diastolic Hypertension, Cardiac Output, High.
What interventions are being tested in trial NCT04755764?
The interventions under investigation include: Labetalol (DRUG), Atenolol (DRUG), Nifedipine (DRUG).
Who is sponsoring clinical trial NCT04755764?
This trial is sponsored by Marshall University, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04755764 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04755764's enrollment target sits among peer trials
60 65th of 99 higher than 31 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI